These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 13196624

  • 1. [Antigenic and immunogenic properties of dry typhus exanthematosus vaccine].
    KARASEVA PS.
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Jul; 7():15-9. PubMed ID: 13196624
    [No Abstract] [Full Text] [Related]

  • 2. [Pathomorphology of local reactions to typhus exanthematosus vaccine following sedimentation].
    GINDIN AP, IATSIMIRSKAIA-KRONTOVSKAIA MK, ZHIV BV, SALAGOVA TA.
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):69-71. PubMed ID: 13257798
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Ricketssial antigens and rickettsial vaccines. 3. An experimental study of the immunogenic properties of live combined typhus E vaccine].
    Ignatovich VF, Morozova MIu.
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):77-80. PubMed ID: 5733865
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on commercial typhus vaccines. II. The antigenic fractions of disrupted epidemic typhus rickettsiae.
    CHAMBERS LA, COHEN SS, CLAWSON JR.
    J Immunol; 1950 Nov; 65(5):459-63. PubMed ID: 14794909
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concepts of louse-borne typhus control in developing countries: the use of the living attenuated E strain typhus vaccine in epidemic and endemic situations.
    Wisseman CL.
    Adv Exp Med Biol; 1972 Nov; 31(0):97-130. PubMed ID: 4211883
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibody response of human subjects to epidemic typhus vaccine three to eight years after previous immunization.
    MURRAY ES, OFSTROCK A, SNYDER JC.
    J Immunol; 1952 Feb; 68(2):207-18. PubMed ID: 14927925
    [No Abstract] [Full Text] [Related]

  • 12. Serologic response in man to varying amounts of inactivated epidemic typhus vaccine.
    Morris JA, Jackson EB, Mufson MA, Bloom HH, Aulisio CG, Smade JE.
    Proc Soc Exp Biol Med; 1967 Jul; 125(3):1009-14. PubMed ID: 15938324
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The immunization of troops with typhus vaccine and the characteristics of typhus in immunized individuals.
    SADUSK JF.
    Yale J Biol Med; 1949 Jan; 21(3):211-32. PubMed ID: 18109885
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibody response to vaccination against murine typhus.
    FOX JP, RICKARD ER.
    Am J Hyg; 1949 May; 49(3):321-39. PubMed ID: 18121212
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; skin-sensitivity following the subcutaneous inoculation of typhus vaccines in man.
    PLOTZ H.
    J Immunol; 1946 Aug; 53():315-9. PubMed ID: 21065180
    [No Abstract] [Full Text] [Related]

  • 19. The constitution of that rickettsia and soluble rickettsial antigen derived from the epidemic typhus vaccine.
    COHEN SS.
    Fed Proc; 1946 Aug; 5(1 Pt 2):129. PubMed ID: 21066650
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.